IGF-1 LR3 active protein-P05019.1
US$ 26.60
bpc 157 and tb-500 cycle BPC-157 + 10mg/10mg BPC-157 and TB-500 Therapy Log
Description
Mechanism of Action 5-Amino-1MQs mechanism centers on selective inhibition of nicotinamide N-methyltransferase, with downstream metabolic effects mediated through changes in cellular methyl-donor availability, NAD + precursor flux, and adipocyte energy expenditure
(2018), BPC-157 exhibits cell-protective properties by safeguarding the integrity of the GI mucosa [8]
Note: Nalidixic acid was the first quinolone antibiotic discovered in the 1960s and used mainly to treat UTIs
Marc Swiontkowski, MD JBJS Editor-in-Chief
This vitamin is key in breaking down homocysteine
